Follow-up of patients with glioblastoma is complicated by the similar appearance of treatment effects and tumor growth on MRI. Perfusion imaging provides a basis for the creation of FTB maps. These visualize the heterogeneity of brain lesions. Quantitative analysis of FTB maps can help differentiate tumor growth from treatment effect with reasonable accuracy.
Herings et al. (Mon,) studied this question.